VGX Pharmaceuticals, LLC

Part of Inovio Pharmaceuticals, Inc.

UEI
GK83K7A8Z9M9
CAGE
4BDS7
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Expired

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Limited Liability Company
Entity structure
Other
Corporate family
SAM.gov registration date

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract awards

Award Agency Obligated Awarded
Aids research (basic) HHSN272200800063C National Institute of Allergy and Infectious Diseases (NIH) $24,297,434
Base period HDTRA107C0104 Defense Threat Reduction Agency $1,990,411

Quick answers

Is VGX Pharmaceuticals, LLC registered in SAM.gov?

VGX Pharmaceuticals, LLC's SAM.gov registration expired on December 17, 2021.

What is VGX Pharmaceuticals, LLC's most recent federal award?

VGX Pharmaceuticals, LLC's most recent federal contract award is Aids research (basic) (HHSN272200800063C), from National Institute of Allergy and Infectious Diseases (NIH), on September 30, 2008.

On GovTribe

See VGX Pharmaceuticals, LLC's full federal record

  • Federal contract awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors